SLU-PP-332: The Future of Exercise in a Pill!

In this episode of The Human 5.0 Project, we dive deep into SLU-PP-332, a groundbreaking compound that promises to revolutionize metabolic health and longevity. Dosing in notes.

What You’ll Learn:

• Origins and Development: Discover how SLU-PP-332 was developed at Saint Louis University and the brilliant minds behind it.

• Mechanism of Action: Learn how this compound mimics exercise at the cellular level, boosting mitochondrial function and metabolic health.

• Current Applications: Explore the therapeutic uses of SLU-PP-332 and how it compares to other metabolic therapies.

• Dosing: Research dosing is oral capsule, 500 µg daily in one or split doses

• Future Prospects: Get a sneak peek into ongoing research and what the future holds for this promising compound.

Join us as we explore the science, benefits, and potential of SLU-PP-332. Don’t forget to like, comment, and subscribe for more deep dives into the latest in biohacking and longevity!

 

For more longevity insights and protocols, check out biohackerdepot.com – your go-to resource for cutting-edge health optimization strategies.

 

And if you're sourcing research peptides , peptidesphere.com has a curated selection of peptides and bioregulators with detailed info on quality and applications.

 

#SLUPP332 #ExerciseInAPill #Biohacking #Longevity #MetabolicHealth #Mitochondria #ERRAgonist #FatLoss #AntiAging #HealthTech #HumanOptimization #PeptideTherapy #ResearchScience #FutureOfHealth